Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...

Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the ...

The Supreme Court last year blocked a previous settlement proposal from Purdue, arguing that the plan would afford the ...

If all creditors opt-in Purdue's settlement in the Opioid lawsuits could total $7.4 billion. Purdue made a formal Chapter 11 filing before a federal bankruptcy court in New York and outlined its ...

NEW YORK, March 19 (Reuters) - Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in cash in the latest plan to settle thousands of lawsuits over the toll of ...

Members of the Sackler family have agreed to pay up to $6.5 billion of the proposed settlement amount over the next 15 years. If the deal is finalized, Purdue is expected to pay about $900 million.